We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.47B
AUM Growth
-$26.4M
Cap. Flow
-$317M
Cap. Flow %
-3.74%
Top 10 Hldgs %
16.75%
Holding
2,295
New
113
Increased
604
Reduced
562
Closed
131

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$44.9M
2
BKNG icon
Booking.com
BKNG
+$30.5M
3
TWX
Time Warner Inc
TWX
+$22.2M
4
MON
Monsanto Co
MON
+$15.5M
5
AAPL icon
Apple
AAPL
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 17.18%
2 Financials 16.58%
3 Healthcare 12.69%
4 Industrials 10.83%
5 Consumer Discretionary 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KNSL icon
1401
Kinsale Capital Group
KNSL
$8.51B
$503K 0.01%
9,172
+2,085
+29% +$110K
RPT
1402
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$502K 0.01%
37,976
CWEN icon
1403
Clearway Energy Class C
CWEN
$7.06B
$501K 0.01%
29,107
BANF icon
1404
BancFirst
BANF
$3.84B
$499K 0.01%
8,433
+1,255
+17% +$73.5K
ROCC
1405
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$499K 0.01%
5,878
-2,320
-28% -$139K
PJT icon
1406
PJT Partners
PJT
$4.36B
$498K 0.01%
9,330
+1,536
+20% +$84.1K
NBHC icon
1407
National Bank Holdings
NBHC
$1.92B
$497K 0.01%
12,889
AYX
1408
DELISTED
Alteryx Inc
AYX
$496K 0.01%
12,993
+1,948
+18% +$68K
KNL
1409
DELISTED
Knoll, Inc.
KNL
$495K 0.01%
23,781
TXMD icon
1410
TherapeuticsMD
TXMD
$24.1M
$493K 0.01%
1,580
+180
+13% +$55K
CORE
1411
DELISTED
Core Mark Holding Co., Inc.
CORE
$493K 0.01%
21,704
SCSC icon
1412
Scansource
SCSC
$1.06B
$490K 0.01%
12,162
HTO
1413
H2O America
HTO
$2.62B
$490K 0.01%
7,394
WT icon
1414
WisdomTree
WT
$3.44B
$487K 0.01%
53,688
PRIM icon
1415
Primoris Services
PRIM
$4.39B
$486K 0.01%
17,845
HOME
1416
DELISTED
At Home Group Inc.
HOME
$486K 0.01%
12,409
+7,006
+130% +$251K
PRSU
1417
Pursuit Attractions and Hospitality Inc
PRSU
$1.27B
$485K 0.01%
8,932
ALDR
1418
DELISTED
Alder Biopharmaceuticals
ALDR
$485K 0.01%
30,681
WEB
1419
DELISTED
Web.com Group, Inc.
WEB
$485K 0.01%
18,763
+2,283
+14% +$45.9K
CHS
1420
DELISTED
Chicos FAS, Inc.
CHS
$484K 0.01%
59,471
+10,808
+22% +$102K
NXGN
1421
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$484K 0.01%
24,814
CSII
1422
DELISTED
Cardiovascular Systems, Inc.
CSII
$484K 0.01%
14,951
SRI icon
1423
Stoneridge
SRI
$197M
$482K 0.01%
13,705
AORT icon
1424
Artivion
AORT
$1.4B
$480K 0.01%
17,220
NCI
1425
DELISTED
Navigant Consulting, Inc.
NCI
$480K 0.01%
21,686

Similar funds

MetLife Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, MetLife Investment Management held 2,295 positions worth $8.47B, down 0.31% from $8.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

MetLife Investment Management withdrew a net $317M in Q2 2018, closing 131 positions and reducing 562 holdings. Its most notable exit was DuPont de Nemours, an estimated $44.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, MetLife Investment Management opened a new position in Bank of New York Mellon worth $16M.

  • MetLife Investment Management's largest Q2 2018 buy was Bank of New York Mellon: 297,519 shares worth $16M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $33.8M increase.
  • MetLife Investment Management's biggest Q2 2018 reduction was Apple, cutting an estimated $14.5M.
  • MetLife Investment Management fully exited DuPont de Nemours in Q2 2018, selling an estimated $44.9M.
  • MetLife Investment Management's ten largest holdings make up 17% of its $8.47B portfolio in Q2 2018.
  • MetLife Investment Management opened 113 new positions and closed 131 in Q2 2018.
  • MetLife Investment Management's portfolio value fell 0.31% quarter-over-quarter to $8.47B.

Based on MetLife Investment Management's 13F filing for Q2 2018, filed 15 Aug 2018.